- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
44
Stocks where the price continues to rise after more than a year of consistent gains.
44 companies
Moderna
Market Cap: US$57.9b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$138.89
7D
115.5%
1Y
447.9%
BioNTech
Market Cap: US$29.3b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$112.82
7D
23.2%
1Y
7.4%
Genscript Biotech
Market Cap: HK$76.6b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$35.04
7D
24.0%
1Y
87.1%
Hanmi Pharm
Market Cap: ₩6.4t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩501,000.00
7D
27.8%
1Y
68.1%
Amylyx Pharmaceuticals
Market Cap: US$4.3b
A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.
AMLX
US$38.15
7D
78.0%
1Y
348.8%
Pell Bio-Med Technology
Market Cap: NT$88.8b
A biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products.
6949
NT$1,355.00
7D
28.4%
1Y
243.9%
Maravai LifeSciences Holdings
Market Cap: US$2.2b
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$8.43
7D
48.4%
1Y
251.3%
Xencor
Market Cap: US$2.1b
A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.
XNCR
US$29.00
7D
25.4%
1Y
262.0%
Personalis
Market Cap: US$2.0b
Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.
PSNL
US$17.06
7D
22.8%
1Y
263.0%
Jenkem Technology
Market Cap: CN¥8.1b
Engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol (PEG), and its derivatives in China and internationally.
688356
CN¥133.41
7D
69.5%
1Y
39.7%
Immix Biopharma
Market Cap: US$977.2m
A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.
IMMX
US$13.61
7D
20.0%
1Y
548.1%
Hunan Hansen Pharmaceutical
Market Cap: CN¥6.2b
Engages in the production and sale of traditional Chinese preparations in China and internationally.
002412
CN¥12.33
7D
61.2%
1Y
77.7%
Novoprotein Scientific
Market Cap: CN¥5.8b
Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.
688137
CN¥83.52
7D
39.2%
1Y
85.1%
Nuvectis Pharma
Market Cap: US$767.6m
A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.
NVCT
US$23.87
7D
25.1%
1Y
267.8%
Shanghai Shenqi Pharmaceutical Investment Management
Market Cap: CN¥5.1b
Operates as a pharmaceutical manufacturing holding investment company in China.
600613
CN¥10.27
7D
32.3%
1Y
45.7%
OmniAb
Market Cap: US$629.5m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$4.71
7D
23.3%
1Y
189.0%
Xinjiang Tianshan Animal Husbandry Bio-engineering
Market Cap: CN¥4.0b
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.
300313
CN¥16.63
7D
29.1%
1Y
76.9%
ACRO Biomedical
Market Cap: NT$15.0b
Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.
6748
NT$210.50
7D
28.7%
1Y
164.4%
Gongwin Biopharm Holdings
Market Cap: NT$14.0b
A clinical-stage biopharmaceutical company, develops anticancer drugs in Hong Kong, China, and Singapore.
6617
NT$115.50
7D
20.2%
1Y
12.1%
Jilin Province Xidian Pharmaceutical Sci-Tech DevelopmentLtd
Market Cap: CN¥2.9b
Engages in the research, development, production, and sales of chemical raw materials and pharmaceutical preparations in China.
301130
CN¥38.72
7D
39.2%
1Y
19.4%
ProQR Therapeutics
Market Cap: US$330.2m
A clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.
PRQR
US$2.43
7D
25.9%
1Y
8.0%
AVITA Medical
Market Cap: US$311.1m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$9.91
7D
25.4%
1Y
113.1%
Circio Holding
Market Cap: NOK 2.6b
A biotechnology company, develops novel circular RNA expression technology for gene and cell therapy.
CRNA
NOK 11.92
7D
40.1%
1Y
1,854.1%
Journey Medical
Market Cap: US$218.7m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.91
7D
22.4%
1Y
6.9%
Nykode Therapeutics
Market Cap: NOK 1.5b
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 4.64
7D
43.4%
1Y
168.2%
Cypherpunk Technologies
Market Cap: US$153.0m
A privacy technology company, implements a digital asset strategy anchored by Zcash in the United States.
CYPH
US$1.68
7D
138.2%
1Y
441.9%
Medivir
Market Cap: SEK 1.1b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 2.08
7D
25.6%
1Y
4.0%
WITHUS PHARMACEUTICALLTD
Market Cap: ₩118.7b
Engages in the production and sale of pharmaceutical products in South Korea.
A330350
₩8,990.00
7D
20.2%
1Y
23.0%
Sareum Holdings
Market Cap: UK£40.2m
A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.
SAR
UK£0.37
7D
27.6%
1Y
76.2%
More Life
Market Cap: CA$34.3m
A biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada.
MLCO
CA$0.08
7D
33.3%
1Y
433.3%
Marker Therapeutics
Market Cap: US$23.2m
A clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.
MRKR
US$1.50
7D
29.3%
1Y
19.0%
1CM
Market Cap: CA$30.0m
A multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada.
EPIC
CA$0.32
7D
57.5%
1Y
12.5%
Pharmala Biotech Holdings
Market Cap: CA$28.9m
A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
MDMA
CA$0.26
7D
36.8%
1Y
108.0%
TME Pharma
Market Cap: €14.7m
A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.
ALTME
€0.13
7D
64.6%
1Y
27.5%
BioVie
Market Cap: US$14.7m
A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.
BIVI
US$2.14
7D
82.9%
1Y
29.7%
Malaysian Genomics Resource Centre Berhad
Market Cap: RM 57.4m
Provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia.
MGRC
RM 0.38
7D
22.6%
1Y
94.9%